Skip to content

Jason V Coloma, Chief Executive Officer at Maze Therapeutics, sold MAZE on Aug 3, 2026

Data as of Oct 16

▼ SELL$4.2K154 shares at $27.09Jason V Coloma Chief Executive OfficerMAZE Maze Therapeutics, Inc.
Watch MAZE
Traded
Aug 3, 2026
Disclosed
Aug 5, 2026
Filed
2 days after the trade

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Jason V Coloma, Chief Executive Officer at Maze Therapeutics, sold MAZE on Aug 3, 2026TRADEDDISCLOSED
MAZESimilar stocks (XLV — its sector index fund), rebased to MAZE's price on the disclosure day
MAZE since disclosure
−1.0%
after the sale
Similar stocks (XLV) since disclosure
+7.6%
XLV — its sector index fund

Change in closing price from Aug 5, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLJason V Coloma Chief Executive OfficerMAZE Maze Therapeutics, Inc.$65.2Kdisclosed Aug 5 · filed 2 days after the trade
  2. ▼ SELLJason V Coloma Chief Executive OfficerMAZE Maze Therapeutics, Inc.$43.4Kdisclosed Aug 5 · filed 2 days after the trade
  3. ▼ SELLJason V Coloma Chief Executive OfficerMAZE Maze Therapeutics, Inc.$810Kdisclosed Aug 5 · filed 2 days after the trade

See every trade on MAZE →